Show simple item record

dc.contributor.authorSananes, A
dc.contributor.authorCohen, I
dc.contributor.authorShahar, A
dc.contributor.authorHockla, A
dc.contributor.authorDe Vita, E
dc.contributor.authorMiller, AK
dc.contributor.authorRadisky, ES
dc.contributor.authorPapo, N
dc.date.accessioned2023-12-11T11:15:34Z
dc.date.available2023-12-11T11:15:34Z
dc.date.issued2018-08
dc.identifier.issn0021-9258
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/92785
dc.format.extent12663 - 12680
dc.languageen
dc.publisherElsevier BVen_US
dc.relation.ispartofJournal of Biological Chemistry
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleA potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringen_US
dc.typeArticleen_US
dc.identifier.doi10.1074/jbc.ra117.000871
pubs.issue33en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttp://dx.doi.org/10.1074/jbc.ra117.000871en_US
pubs.volume293en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States